Buy Ajanta Pharma; target of Rs 4000: Motilal Oswal

Motilal Oswal has a 'buy' rating on Ajanta Pharma with a target price of Rs 4000.

The rating is part of a research report dated July 30, 2026.

The report suggests the stock is expected to rise to Rs 4000.